DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 48 · March 2015 DOI: 10.1055/s-005-28734

AGNP News

  • I
  • Review

  • 41
  • Original Paper

  • 51
    Toledo-Romero, F.; Molina, J. D.; López-Rodríguez, E.; Amorin-Díaz, M.; Muñoz Algar, M. J.; Aparicio-Castro, E.:

    Augmentation with Amisulpride for Schizophrenic Patients Non-Responsive to Risperidone Monotherapy

  • 58
    Tsai, H. C.; Lin, S.-H.; Chen, P. S.; Chang, H. H.; Lee, I. H.; Yeh, T. L.; Chen, K. C.; Chiu, N. T.; Yao, W. J.; Liao, M.-H.; Yang, Y. K.:

    Quantifying Midbrain Serotonin Transporter in Depression: A Preliminary Study of Diagnosis and Naturalistic Treatment Outcome

  • 65
    Brunnauer, A.; Buschert, V.; Fric, M.; Distler, G.; Sander, K.; Segmiller, F.; Zwanzger, P.; Laux, G.:

    Driving Performance and Psychomotor Function in Depressed Patients Treated with Agomelatine or Venlafaxine

  • 72
    Wolf, L.; Bauer, A.; Melchner, D.; Hallof-Buestrich, H.; Stoertebecker, P.; Haen, E.; Kreutz, M.; Sarubin, N.; Milenkovic, V. M.; Wetzel, C. H.; Rupprecht, R.; Nothdurfter, C.:

    Enhancing Neurosteroid Synthesis – Relationship to the Pharmacology of Translocator Protein (18 kDa) (TSPO) Ligands and Benzodiazepines

  • Letter

  • 78
    Permoda-Osip, A.; Kisielewski, J.; Bartkowska-Sniatkowska, A.; Rybakowski, J. K.:

    Single Ketamine Infusion and Neurocognitive Performance in Bipolar Depression

  • 80
  • Erratum

  • 81
    Proft, F.; Kopf, J.; Olmes, D.; Hempel, S.; Schmidt, B.; Riederer, P.; Deckert, J.; Pfuhlmann, B.; Reif, A.; Unterecker, S.:

    SLC6A2 and SLC6A4 Variants interact with Venlafaxine Serum Concentrations to Influence Therapy Outcome